ProPhase Labs (NASDAQ:PRPH) CEO Ted Karkus joins Natalie Stoberman in the Proactive studio to break down how the company has transformed in the biotech industry, as well as how the company's third quarter is leading to more growth for 2023.
ProPhase Labs (NASDAQ:PRPH) is a growth oriented and diversified diagnostics, genomics and biotech company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and build a genomics database to be used for further research.